HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.

AbstractOBJECTIVES:
The role of the immunomodulator tuftsin in enhancing the antifungal activity of liposomal amphotericin B against Cryptococcus neoformans in leucopenic mice was assessed.
METHODS:
In the present study, we investigated the antifungal activity of amphotericin B liposomes with tuftsin grafted on the surface. Mice were treated with free amphotericin B as well as liposomal formulations after C. neoformans infection. For prophylactic studies, mice were pre-treated with liposomal tuftsin (50 microg/mL) for three consecutive days prior to C. neoformans infection (7 x 10(5) cfu/mouse). Chemotherapy, with tuftsin-free and tuftsin-bearing amphotericin B liposomes, was started 24 h post C. neoformans infection. The role of tuftsin in immunoaugmentative therapy was assessed by survival and cfu of treated mice.
RESULTS:
Amphotericin B entrapped in tuftsin-bearing liposomes showed increased anticryptococcal activity in the murine model. Moreover, tuftsin pre-treatment further augmented the antifungal activity of liposomal amphotericin B in leucopenic mice. Incorporation of tuftsin in liposomes resulted in increased anticryptococcal activity of liposomal amphotericin B compared with amphotericin B deoxycholate and conventional liposomal amphotericin B formulations.
CONCLUSIONS:
The enhanced anticryptococcal activity of amphotericin B in tuftsin-liposomes can be attributed to the immune-stimulating property of tuftsin. Tuftsin activates the key immune cells, due to the presence of its receptors on macrophages and neutrophils, for a better fight against pathogens. Simultaneous liposome-mediated delivery of amphotericin B to the site of infection kills the pathogens more effectively.
AuthorsMasood A Khan, Tahseen H Nasti, M Owais
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 56 Issue 4 Pg. 726-31 (Oct 2005) ISSN: 0305-7453 [Print] England
PMID16126780 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
  • Immunologic Factors
  • Liposomes
  • liposomal amphotericin B
  • Amphotericin B
  • Tuftsin
Topics
  • Amphotericin B (administration & dosage, chemistry)
  • Animals
  • Antifungal Agents (administration & dosage)
  • Brain (microbiology)
  • Cryptococcosis (complications, drug therapy, immunology)
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Immunologic Factors (administration & dosage, chemistry, immunology)
  • Leukocytes (drug effects)
  • Leukopenia (complications)
  • Liposomes (administration & dosage, metabolism)
  • Lung (microbiology)
  • Mice
  • Mice, Inbred BALB C
  • Tuftsin (administration & dosage, chemistry, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: